BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 782973)

  • 1. Clinical trials carried out to assess non-parenteral routes for administration of Wistar RA 27/3 strain live attenuated rubella vaccine.
    Freestone DS
    Dev Biol Stand; 1976; 33():237-40. PubMed ID: 782973
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intranasal versus subcutaneous rubella vaccination in schoolgirls.
    Midulla M; Assensio AM; Balducci L; Vanni O; Msstropasqua S
    Dev Biol Stand; 1976; 33():241-8. PubMed ID: 955270
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vaccination by non-parenteral routes: characteristics of immune response.
    Ogra PL; Chiba Y; Beutner KR; Morag A
    Dev Biol Stand; 1976; 33():19-26. PubMed ID: 782968
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Rubella screening in school girls using the radial hemolysis test and their vaccination with attenuated live vaccine of the RA23/3 strain].
    Strauss J; Benes C; Macátová I
    Z Gesamte Hyg; 1988 Oct; 34(10):589-91. PubMed ID: 3201803
    [No Abstract]   [Full Text] [Related]  

  • 5. [Rubella screening and directed vaccination of 14-year-old girls with live rubella vaccine RA 27/3 in the Liberec district].
    Strauss J; Zikmundová V; Stovicek Z; Zikmund V; Téminová V; Langhammer O; Kokesová O
    Cesk Epidemiol Mikrobiol Imunol; 1982 Sep; 31(5):266-76. PubMed ID: 6215992
    [No Abstract]   [Full Text] [Related]  

  • 6. [Improvement of rubella vaccination. Seroconversion after serial rubella vaccination with the jet injector].
    Weber HG; Willers H
    Fortschr Med; 1982 Jun; 100(24):1161-3. PubMed ID: 7106679
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Vaccination against rubella. A comparison of intranasal and subcutaneous aadministration of the vaccination strain RA 27-3 (author's transl)].
    Petersen EE; Büche M; Doerr HW; Neumann-Haefelin C; Luthardt T; Göttsching C; Haas R
    Dtsch Med Wochenschr; 1973 Oct; 98(40):1842-7. PubMed ID: 4762037
    [No Abstract]   [Full Text] [Related]  

  • 8. Safety and immunogenicity of concurrent administration of live attenuated influenza vaccine with measles-mumps-rubella and varicella vaccines to infants 12 to 15 months of age.
    Nolan T; Bernstein DI; Block SL; Hilty M; Keyserling HL; Marchant C; Marshall H; Richmond P; Yogev R; Cordova J; Cho I; Mendelman PM;
    Pediatrics; 2008 Mar; 121(3):508-16. PubMed ID: 18310199
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Absence of cell-mediated immunity to rubella virus 5 years after rubella vaccination.
    Rossier E; Phipps PH; Polley JR; Webb T
    Can Med Assoc J; 1977 Mar; 116(5):481-4. PubMed ID: 837312
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A clinical trial of WRL 105 strain live attenuated influenza vaccine comparing four methods of intranasal vaccination.
    White WG; Freestone DS; Bowker CH; Barnes GM; Letley E; Ferris RD
    Dev Biol Stand; 1976; 33():202-6. PubMed ID: 782970
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Studies on the live attenuated rubella virus vaccine. III. Clinical trials with rubella virus (Takahashi strain) vaccine in children and women.
    Yamane Y; Nagashima T; Asahara T; Nagamine T; Kawakubo Y
    Kitasato Arch Exp Med; 1974 Sep; 47(3):89-100. PubMed ID: 4459505
    [No Abstract]   [Full Text] [Related]  

  • 12. Persistence of antibody titers after vaccination with rubella virus vaccine ("Cendehill" strain).
    Peetermans J; du Pan RM; Huygelen C
    Dev Biol Stand; 1979; 43():361-5. PubMed ID: 520683
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Evaluation of the specific immune response after anti-rubella vaccination].
    Cellesi C; Rossolini A; Rossolini GM; Bianchi Bandinelli ML; Cusi MG; Egisto Valensin P
    Quad Sclavo Diagn; 1988; 24(1-4):97-105. PubMed ID: 3268925
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Passive immunization against rubella: studies on the effectiveness of rubella-immunoglobulin after intranasal infection with rubella vaccination virus].
    Neumann-Haefelin D; Neumann-Haefelin Ch; Petersen EE; Luthardt Th; Hass R
    Dtsch Med Wochenschr; 1975 Jan; 100(5):177-81. PubMed ID: 1112230
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of simultaneous administration of live measles vaccine on the "take rate" of live mumps vaccine.
    André FE; Peetermans J
    Dev Biol Stand; 1986; 65():101-7. PubMed ID: 3556770
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Studies on live rubella vaccine. IV. Comparative field trials with attenuated vaccines at different passage levels in Japanese quail embryo fibroblast cells.
    Minekawa Y; Suzuki N; Osame J; Ueda S; Yamanishi K
    Biken J; 1973 Dec; 16(4):155-60. PubMed ID: 4799207
    [No Abstract]   [Full Text] [Related]  

  • 17. Vaccination with combined live measles and rubella vaccines.
    Ramos Alvarez M; Bessudo L
    Rev Invest Salud Publica; 1972; 32(2):110-5. PubMed ID: 4584450
    [No Abstract]   [Full Text] [Related]  

  • 18. Rubella vaccine in the People's Republic of China.
    Han YR; Zhao K; Gong YX; Hao SL; Wang SZ; Wang CT
    Rev Infect Dis; 1985; 7 Suppl 1():S79. PubMed ID: 4001739
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Studies on live rubella vaccine. 3. Field trials with vaccines attenuated by serial passages in primary pig kidney cells.
    Suzuki M; Minekawa Y; Osame J; Ueda S; Ogino T
    Biken J; 1973 Dec; 16(4):149-54. PubMed ID: 4799206
    [No Abstract]   [Full Text] [Related]  

  • 20. Success and failure of a rubella immunization programme.
    Swartz TA; Porath EB; Hornstein L
    Dev Biol Stand; 1979; 43():355-60. PubMed ID: 520682
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.